An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).

NCT06339060 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

356

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

COMBINATION_PRODUCT: Experimental: Arm 1 Organ preservation
COMBINATION_PRODUCT: Active Comparator: Arm 2 Surgery

Sponsor

Ruijin Hospital